Recent Articles from Investor Brand Network

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

OptimumBank Holdings (NYSE American: OPHC), a community and business bank serving Florida, entered 2026 on the heels of a broad reworking of its capital structure, a process management describes as laying a clearer foundation for the company’s next phase of growth. “The initiative, detailed in a Jan. 5 announcement , reflects coordinated actions by OptimumBank’s largest institutional investor and key insiders, with an emphasis on transparency, alignment, and long-term flexibility,” reads a recent article. “The Fort Lauderdale-based holding company said the changes were undertaken to modernize legacy equity arrangements and to better reflect the scale the institution has reached. OptimumBank Holdings, Inc. surpassed $1.1 billion in assets last year, a milestone that Chairman Moishe Gubin has cited as a natural point to reassess how capital is structured and presented to the market.”

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) and may include paid advertising.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

Bitcoin has shown relative stability even as geopolitical tensions intensify in the Middle East and broader financial markets face mounting pressure.

Data pooled from tens of thousands of electric vehicles is delivering a verdict that should reassure anyone who ever hesitated over buying an EV. Batteries are holding up far better than anyone predicted when the first modern electric cars reached consumers.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Massimo Group (NASDAQ: MAMO) a manufacturer and distributor of powersports vehicles, utility vehicles and related equipment, announced that a long-standing national rural lifestyle retail partner has authorized one of the company’s core products for placement across 1,000 U.S. retail locations. The initial rollout will include approximately 2,400 units supported through both physical retail stores and the retailer’s online platform, establishing an integrated omnichannel sales approach and creating a scalable pathway for potential expansion across the retailer’s roughly 2,200 U.S. locations, subject to performance and ongoing evaluation.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

Modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism can unlock treatments for multiple diseases. Rather than building entirely new molecules for every indication, companies are developing platform technologies that allow a single therapeutic approach to be adapted across conditions. Soligenix (NASDAQ: SNGX) exemplifies this strategy through its use of synthetic hypericin across two distinct dermatologic indications, illustrating how platform science can streamline development and expand clinical impact.

Aditxt (NASDAQ: ADTX), a social innovation platform accelerating promising health innovations, announced it will implement a 1-for-8 reverse stock split of its common stock effective at the opening of trading on March 9, 2026, while continuing to trade on the Nasdaq Capital Market under the symbol ADTX. The reverse split, approved by stockholders at a Feb. 13, 2026 special meeting and finalized by the company’s board of directors, is intended primarily to help the company regain compliance with Nasdaq’s minimum bid price requirement.

Frontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, today announced the appointment of Nora Shepard as vice president of communications as the company advances commercialization of its first FASForm(TM) facility in Mason County, West Virginia and expands engagement with institutional investors, strategic partners and policymakers. In her new role, Shepard will oversee corporate communications, investor messaging, brand strategy and executive positioning, supporting Frontieras’ efforts to align operational execution with capital markets strategy as it progresses toward deployment of its flagship facility designed to process 7,500 tons of coal per day.

Anthropic’s AI assistant Claude surged to the top of Apple’s list of most downloaded free apps in the U.S. on Saturday evening, just one day after the Trump administration moved to prevent federal agencies from adopting the company’s technology.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the enrollment of the first patients in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The first patients were enrolled by Prof. Dr. Vladan Vukcevic at the University Clinical Center of Serbia in Belgrade, marking a key step toward generating the clinical data needed to expand the HeartBeam System’s indication beyond arrhythmia assessment to include heart attack detection.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, will host a conference call at 4:30 p.m. Eastern time on March 12, 2026, to discuss its financial results for the fourth quarter and full year ended Dec. 31, 2025, and provide updates on key strategic growth initiatives, including the limited commercial launch and progress on its 12-lead ECG extended wear patch. A press release detailing the results will be issued prior to the call.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

Trump’s assault on Iran has produced an outcome he almost certainly did not plan for: a powerful, real-world advertisement for ditching fossil fuels. With energy markets destabilized and drivers across the world bracing for another squeeze at the pump, the economic case for clean energy has rarely felt more urgent or better supported.

As many companies work to put autonomous vehicles (self-driving cars) on roads, scientists are working to find ways to increase the safety of these vehicles not just for the passengers they carry but also for those in the environment, such as cyclists and pedestrians. A team of researchers has come up with a concept involving installing radar sensors on roadsides to augment the onboard sensors in autonomous vehicles.

The International Energy Agency (IEA) has warned about growing risks in the global battery market as demand for energy storage continues to rise. Lithium-ion battery energy storage systems, or BESS, have become a key part of modern power systems. Over the last five years, global battery storage capacity has grown twenty times, driven by falling prices, abundant supply, and shorter project lead times.

Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across high-growth sectors, today announced that America First Defense (“AFD”) has secured a license for the Detachable Drone Highjacker (“DDH”), a drone-mounted electronic warfare payload originally developed at the Naval Postgraduate School to counter hostile unmanned aircraft systems (“UAS”). The DDH is designed to attach to a friendly drone and neutralize enemy drones through targeted cyber operations rather than broad-spectrum jamming, enabling selective, precision defeat of hostile UAS and positioning AFD to further develop and commercialize a scalable airborne counter-UAS capability for defense, security and critical infrastructure protection applications.

The start of this week saw the price of gold surge sharply, climbing to roughly $5,400 per troy ounce and marking its highest level in weeks. The move reinforced the metal’s role as a preferred safe-haven asset amid intensifying geopolitical strain, with futures prices advancing by over 2% during the session. This highlights strong investor demand for defensive positioning.

The media has been awash with stories of intense sweeps by Immigration and Customs Enforcement (ICE) conducted in different cities, such as Minneapolis. While a lot of focus has been on the sometimes high-handed methods used during these operations, a team of researchers is drawing attention to the adverse public health effects of these ICE sweeps.

Oklahoma lawmakers are weighing another extension of the state’s pause on issuing new medical cannabis business licenses, a move that could also lead to a long-term limit on the number of grow operations once the freeze is lifted.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Olenox Industries (NASDAQ: OLOX), a multifaceted energy company, announced that its well revitalization efforts in the Wichita field are meeting production targets, with 10 wells successfully revitalized since December 2025 and 25 additional wells expected online by the end of the first quarter. The Company deployed a dedicated rig in December and reports stabilized production, with its original target of 70 barrels per day within reach and anticipated to be met or exceeded by month’s end, according to CEO Michael McLaren. Olenox said it plans to bring additional wells into production weekly, continue workover and drilling activities and evaluate more than 6,000 acres for potential acquisitions to further expand output.

Healthcare delivery is being reshaped by two forces that often move at different speeds: consumer demand for faster access and more personalized care, and institutional requirements for stronger compliance, reporting, and audit readiness. Telemedicine adoption has normalized virtual visits, while pharmacy and fulfillment models increasingly compete on speed, service, and regulatory execution. For multi-subsidiary healthcare operators, the differentiator is not simply growth, but the ability to scale responsibly across jurisdictions, products, and clinical workflows without losing control of governance and financial discipline.

ParaZero Technologies (NASDAQ: PRZO) an aerospace defense company focused on smart autonomous solutions for the global manned and unmanned aerial systems industry, announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Noy brings more than 20 years of commercial and leadership experience, including her most recent role as Business Unit Lead for Rare Diseases at Pfizer Israel from 2020 to 2025, where she was responsible for strategy, team development and overall business performance. ParaZero said her background in strategic planning, market access and cross-functional leadership will support the company’s efforts to expand its global commercial presence in the growing drone safety and aerospace sector.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

GridAI Technologies (NASDAQ: GRDX) announced that Amp Z has been identified as the previously disclosed stealth-mode hyperscale artificial intelligence data center developer referenced in the Company’s November 2025 Letter of Intent announcement. Under the LOI, GridAI is expected to serve as the energy orchestration and optimization platform across Amp Z’s planned 5GW-plus portfolio of AI data center campuses in North America over the next five to 10 years. GridAI’s platform is designed to coordinate onsite and grid-connected energy resources, including battery storage, distributed generation and renewable integration, into a unified operating system that supports speed-to-power, reliability and cost optimization. The collaboration is structured to generate recurring operating revenue tied to long-term campus performance, aligning with federal policy encouraging privately funded energy infrastructure to support AI-driven electricity demand while protecting ratepayers.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated commercial biotechnology company, announced that a poster on Tonmya(TM) (cyclobenzaprine HCl sublingual tablets), investigated as TNX-102 SL, will be presented at the 2026 PainConnect Annual Meeting hosted by the American Academy of Pain Medicine (AAPM). The meeting is scheduled for March 5-8, 2026, in Salt Lake City, Utah, where the Company will share data related to its investigational therapy as part of the scientific program.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated commercial biotechnology company, announced that a poster on Tonmya(TM) (cyclobenzaprine HCl sublingual tablets), investigated as TNX-102 SL, will be presented at the 2026 PainConnect Annual Meeting hosted by the American Academy of Pain Medicine (AAPM). The meeting is scheduled for March 5-8, 2026, in Salt Lake City, Utah, where the Company will share data related to its investigational therapy as part of the scientific program.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Reports indicate the U.S. military was still running Anthropic’s AI models during strikes on Iran even after President Trump had formally ordered all federal agencies to stop using models developed by Anthropic.

Many companies are still testing artificial intelligence in small ways. They use it to create reports, suggest insights, or automate simple tasks. But in most cases, AI is still in the “experiment” stage. Procurement may be the first business function ready to move beyond experiments and show what agentic AI can really do.

As early trading got underway on Wednesday, gold prices climbed for their fifth day in a row as the conflict in the Middle East stoked demand for this safe-haven asset. Energy markets were also thrown out of whack as strikes against Iran upended trade routes, especially the Strait of Hormuz.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, announced a commercial partnership with ClearCardio(TM), a preventive cardiology practice serving thousands of patients through heart health screening and personalized prevention programs. ClearCardio will serve as HeartBeam’s first commercial customer and plans to make an investment in the company, underscoring strategic alignment. The staged rollout will integrate HeartBeam’s synthesized 12-lead ECG technology into ClearCardio’s cardiac prevention program for arrhythmia assessment, enabling patients to capture clinical-grade ECG readings from home using HeartBeam’s patented cable-free 3D ECG system. Structured as a Letter of Intent outlining subscription-based commercial terms and a collaborative deployment plan, the agreement supports HeartBeam’s broader growth strategy, including expansion into concierge care and preventive cardiology networks, continued development of its 12-lead ECG patch monitor and advancement of its AI-driven cardiac care initiatives.

Two issues that rarely share political ground are now colliding at the highest court in the country. Firearm rights and marijuana policy have each reshaped U.S. law and politics over the past few decades. Recently, they met in a Supreme Court case that has produced an unexpected mix of allies and opponents.

Select Water Solutions (NYSE: WTTR) announced the pricing of an underwritten public offering of 13,725,491 shares of its Class A common stock at a public offering price of $12.75 per share pursuant to an effective Form S-3 shelf registration statement filed with the SEC. The company intends to use the net proceeds for general corporate purposes, including water infrastructure growth capital projects, potential acquisitions and debt repayment under its sustainability-linked credit facility. The company granted underwriters a 30-day option to purchase up to 2,058,824 additional shares at the public offering price, less underwriting discounts and commissions. J.P. Morgan and BofA Securities are serving as lead book-running managers, with Citigroup, Piper Sandler and Raymond James as joint book-running managers and Roth Capital Partners among the co-managers. The offering is expected to close on Feb. 23, 2026, subject to customary conditions.

MicroVision (NASDAQ: MVIS) announced it has strengthened its financial position through the issuance of senior secured convertible notes totaling $43.0 million, deferring existing repayment obligations and supporting acceleration of anticipated acquisition synergies. Management said the new capital, secured in partnership with High Trail Capital, enhances the company’s ability to integrate recently acquired assets and operations from Luminar Technologies and Scantinel Photonics, while securing production capacity and accelerating product deliveries as it advances customer engagement and rebuilds commercial relationships. WestPark Capital, Inc. served as exclusive placement agent for the transaction.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Micropolis AI Robotics (NYSE American: MCRP) announced it has entered into a comprehensive commercial agreement with AfricAI Limited that includes a $9.3 million, 18-month program to design and develop three customized unmanned ground vehicle platforms tailored for African operating environments, as well as a three-year distribution agreement covering key markets. The new UGV models will target police and public safety, agricultural automation and border control applications, with pilot testing planned across selected African sites prior to commercialization. Under the distribution framework, AfricAI, through its subsidiary AfricaAI Technology FZ LLC, will hold exclusive rights across ECOWAS member states, South Africa, the Democratic Republic of Congo and Tanzania, purchasing and marketing both Micropolis’ existing M-Patrol models and newly developed systems.

Micropolis AI Robotics (NYSE American: MCRP) announced it has entered into a comprehensive commercial agreement with AfricAI Limited that includes a $9.3 million, 18-month program to design and develop three customized unmanned ground vehicle platforms tailored for African operating environments, as well as a three-year distribution agreement covering key markets. The new UGV models will target police and public safety, agricultural automation and border control applications, with pilot testing planned across selected African sites prior to commercialization. Under the distribution framework, AfricAI, through its subsidiary AfricaAI Technology FZ LLC, will hold exclusive rights across ECOWAS member states, South Africa, the Democratic Republic of Congo and Tanzania, purchasing and marketing both Micropolis’ existing M-Patrol models and newly developed systems.

TransCode Therapeutics (NASDAQ: RNAZ) announced it has entered into an exclusive, worldwide, fully paid-up royalty-free license agreement with Unleash Immuno Oncolytics, Inc., obtaining rights to develop three drug candidates — UIO-524, UIO-525 and UIO-526 — including all in-licensed and owned rights held by Unleash. Under the agreement, Unleash will receive a one-time payment of 1,136,364 shares of a new series of non-voting convertible preferred stock, convertible into an equal number of common shares and representing 6.8% of TransCode’s common stock on a fully diluted basis. The lead candidate, UIO-524, is a next-generation oncolytic adenovirus engineered to selectively replicate in malignant cells and cancer-associated stroma, delivering a multi-cytokine immune-activating payload aimed at treating solid tumors, initially targeting muscle-invasive bladder cancer. The company said the addition of UIO-524 expands its oncology pipeline alongside its lead asset, TTX-MC138, which is advancing toward a Phase 2a clinical trial.

Renewal Fuels (OTC: RNWF) issued commentary on escalating military conflict between the United States and Iran, stating that potential disruption of oil shipments through the Strait of Hormuz underscores structural vulnerabilities in fossil fuel dependence and strengthens the strategic case for domestically sourced, non-intermittent clean energy such as fusion. The company highlighted ongoing development of its Texatron(TM) aneutronic fusion platform through Kepler Fusion Technologies, noting the recent closing of its transaction with Kepler, expansion of its patent portfolio to 20 filed applications with approximately 240 additional applications in development, near-term Form 10 filing readiness and strengthening of its leadership team. Management said geopolitical instability reinforces the long-term relevance of compact, modular fusion systems designed to provide continuous baseload power independent of hydrocarbon supply chains.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently finished the company’s first full reporting period as the world’s largest Solana treasury. In a recent announcement of the company’s fiscal first quarter 2026 operating and financial results, FWDI shared updates about the company, as well as detailing milestones and future plans ( https://ibn.fm/RcNVx ).

Olenox Industries (NASDAQ: OLOX) announced that its 2026 drilling program is underway, with well locations identified and seismic data acquisition scheduled to begin this month. The company plans to drill one well by the end of the current calendar quarter, followed by three wells in each of the second, third and fourth quarters of 2026. Olenox has completed a pipeline survey and is preparing paperwork to recommission and relicense its 162-mile pipeline, which is expected to be fully operational by the end of the third quarter. The company is also evaluating wells connected to the pipeline as potential acquisitions and aims to reach production of 1,000 barrels of oil equivalent per day by year-end.

Uranium Energy (NYSE American: UEC) announced it will release its fiscal 2026 second quarter operating and financial results before the markets open on Tuesday, March 10, 2026.

Datavault AI (NASDAQ: DVLT) highlighted a significant increase in institutional ownership between the fourth quarter of 2025 and February 2026, with Vanguard expanding its holdings to approximately 11.8 million shares, State Street increasing to about 10.0 million shares and BlackRock growing its position to roughly 4.1 million shares, representing percentage increases of approximately 2,900%, 2,800% and 3,000%, respectively, according to public filings. Management attributed the heightened institutional participation to the company’s expanding enterprise adoption, strategic acquisitions and high-profile commercial partnerships, including agreements with Sports Illustrated and NFL Alumni and the acquisition of API Media. The company also noted a previously announced $150 million strategic investment from Scilex Holding Company as it continues scaling its data monetization, credentialing and real-world asset tokenization platform.

This article has been disseminated on behalf of Ecolomondo Corporation and may include paid advertising.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced it has received approval from Nasdaq to transfer the listing of its common stock from the Nasdaq Capital Market to the Nasdaq Global Select Market, with trading on the higher tier expected to begin at the open of market on March 3, 2026, under the existing ticker symbol “TNXP.” The move reflects the company’s compliance with the Nasdaq Global Select Market’s more stringent financial and corporate governance requirements and is expected to enhance institutional visibility, liquidity and broader market recognition. Management described the uplisting as an important milestone as the company continues to focus on growth and shareholder value creation.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Gaxos.ai (NASDAQ: GXAI) announced it has acquired a 19.99% stake in America First Defense, a U.S.-based defense technology company developing next-generation drone and robotics platforms across air and ground domains. America First Defense is focused on a detachable counter-drone system designed to neutralize hostile UAVs through precise protocol-level cyber attacks and a biomimetic soft robotics platform engineered for low-detection ground and subsurface operations, targeting demand from U.S. defense, homeland security, border security, maritime security, municipal safety and critical infrastructure operators. Gaxos said the investment expands its exposure to American-owned defense innovation and aligns with its strategy to build a diversified portfolio of AI-driven businesses and strategic investments across high-growth sectors.

Safe Pro Group (NASDAQ: SPAI), a tech company that delivers defense and security solutions, recently announced that it has been awarded a subcontract agreement to supply the U.S. Government AI processing systems under a $1,000,000 subcontract from a prime contractor ( https://ibn.fm/VjB2Z ).

Knightscope (NASDAQ: KSCP) announced it has completed the acquisition of Event Risk LLC, a nationwide provider of armed and unarmed guarding services and executive protection, establishing a vertically integrated operating structure that combines autonomous security robots, AI-driven command software and licensed human response under a single contract. The transaction enables Knightscope to participate in enterprise engagements requiring licensed guarding providers while expanding its share of total contract value through an integrated managed service model. Event Risk, which has demonstrated consistent double-digit growth and positive EBITDA entering 2026, will continue to be led by Eric J. Rose and is expected to transition to the Knightscope Security Force brand during 2026. The acquisition includes cash, common stock and performance-based consideration, with additional details available in the company’s SEC filings.

This article has been disseminated on behalf of Ecolomondo Corporation and may include paid advertising.

ClearThink 1 Acquisition (NASDAQ: CTAAU) announced the closing of its initial public offering of 12,500,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share upon completion of an initial business combination. The units began trading on the Nasdaq Global Market on Feb. 24, 2026, under the symbol “CTAAU,” with the Class A ordinary shares and share rights expected to trade separately under “CTAA” and “CTAAR,” respectively. On Feb. 27, 2026, the company closed on a partial over-allotment of 15,000 units, bringing total gross proceeds from the offering to approximately $125 million. D. Boral Capital LLC acted as sole bookrunner for the offering.

ECGI Holdings (OTC: ECGI) shared a management update highlighting progress on its RezyFi mortgage real-world asset tokenization initiative, including a live pilot tied to mortgage loans originated by ResMac, a wholly owned RezyFi subsidiary. In a recent CEO interview, management outlined key pilot objectives centered on validating a repeatable workflow capable of supporting an initial pooled offering, with stable technical performance, accurate on-chain mortgage representation and reliable loan life-cycle tracking. The company detailed core platform “rails” under validation, including token creation, servicing payment mapping and investor reporting, while discussing a potential transaction-based fee model encompassing tokenization, origination, structuring, platform usage and life-cycle event fees. Management identified completion of pilot validation, pooled structure readiness and first pooled offering workflow capability as critical checkpoints aimed at reducing execution risk prior to broader rollout.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Duos Technologies Group (NASDAQ: DUOT) announced the pricing of an underwritten public offering of 8,666,666 shares of its common stock for gross proceeds of approximately $65 million, before underwriting discounts and expenses. The company granted underwriters a 30-day option to purchase up to an additional 1,299,999 shares to cover over-allotments. The offering is expected to close on or about March 2, 2026, subject to customary conditions, with net proceeds earmarked to accelerate commercialization and expansion of its Edge Data Center business, as well as for working capital and general corporate purposes. Titan Partners, a division of American Capital Partners, is serving as sole bookrunner.

Ideal Power (NASDAQ: IPWR) announced the pricing of an underwritten public offering of 4,458,736 shares of common stock, or pre-funded warrants in lieu thereof, for gross proceeds of approximately $12.3 million, alongside a concurrent private placement of pre-funded warrants to purchase up to 631,332 shares for approximately $1.7 million in gross proceeds, bringing total expected gross proceeds to about $14.0 million before expenses. The financings are expected to close on Feb. 25, 2026, subject to customary conditions, and include participation from existing institutional shareholders and company insiders, including the CEO. Net proceeds will support commercialization of the company’s B-TRAN(R) bidirectional semiconductor power switch, including customer design-ins, custom development programs and initial production ramp, as well as general corporate and working capital purposes. Titan Partners, a division of American Capital Partners, is serving as sole bookrunner.

Following coordinated military strikes by Israel and the United States on Iran, fears of a significant disruption to Middle Eastern oil supplies have heightened, with some arguing that extreme outcomes may push the global economy into recession.

Volkswagen has officially delivered more than two million electric vehicles, a landmark achievement that underscores just how far the German automaker has traveled since first entering the battery-electric segment over a decade ago. The milestone unit was an ID.3 , assembled at its Saxony facility and collected by its new owner at a dedicated handover center in Dresden.

Researchers at Keck Medicine, University of Southern California (USC) have discovered that combining immunotherapy with laser heat therapy could significantly extend the survival of individuals diagnosed with deadly brain cancers.

President Donald Trump has ordered federal departments to halt the use of AI tools developed by Anthropic, escalating a dispute between the White House and the fast-growing technology firm.

Equity research reports often serve as important barometers of shifting sentiment, offering investors detailed analysis of a company’s strategy, risks and growth potential. In a new research note, Joseph Gunnar & Co. upgraded HeartBeam (NASDAQ: BEAT) from Hold to Buy and raised its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization. A medical tech company, HeartBeam will introduce its FDA-cleared cable-free, synthesized 12-lead ECG system designed to deliver clinical-grade cardiac insights for arrhythmia assessment in a portable format, and the upgrade reflects growing confidence in the company’s commercial launch strategy and long-term opportunity.

Linkers Industries Limited (NASDAQ: LNKS) announced that on Feb. 27, 2026, it received a notification letter from The Nasdaq Stock Market LLC confirming the company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq determined that Linkers maintained a closing bid price of at least $1.00 per ordinary share from Jan. 29, 2026, through Feb. 26, 2026, and the listing matter has been closed. The company’s Class A ordinary shares continue to trade on Nasdaq under the symbol “LNKS.”

Europe sits on a major renewable energy opportunity that keeps slipping through its fingers. Costs have fallen sharply, the technology works, and the strategic case for cutting fossil fuel dependence has never been more obvious. Four stubborn obstacles, however, are standing between the continent and the clean energy future its own economics demand.

The crypto markets slid over the weekend after Israel and the United States carried out coordinated military strikes in Iran on Saturday, February 28, rattling global markets and prompting investors to pull back from higher-risk holdings.

A new report published by Netcore shows that ecommerce brands that focused on execution tended to pull ahead of those that simply spent more on incorporating AI tools without determining how exactly those tools would deliver results. In this case, strategic execution trumped blind integration .

Morgan Stanley has taken another big step into the world of cryptocurrencies. On February 18, 2026, the financial giant submitted an application to the Office of the Comptroller of the Currency (OCC) to establish a federally chartered digital asset trust bank. The proposed bank, called Morgan Stanley Digital Trust, National Association (MSDTNA), aims to provide digital asset services to clients across the United States under federal supervision.

Cannabis remains listed as a Schedule I substance under the Controlled Substances Act (CSA), a category reserved for drugs considered to have a high likelihood of misuse and no recognized medical purpose. That designation has shaped federal drug policy for decades and continues to influence workplace rules across the country.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced execution of a Second Amendment to its Binding Option Agreement for the acquisition of PinCell S.r.l. and submission of a revised application under the European Funds for the Modern Economy SMART Path program. The updated application seeks €12 million in non-dilutive, non-repayable funding to support a €15 million integrated R&D program for PC111, a fully human monoclonal antibody targeting soluble Fas Ligand for the treatment of pemphigus vulgaris and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis, representing 80% co-financing. The amendment extends the option condition deadline to Aug. 31, 2026, and the exercise period to Sept. 30, 2026, aligning with the anticipated three- to four-month grant review timeline as the Company advances PC111 toward early clinical development and human proof of concept.